DARK BLUE THERAPEUTICS LTD
Research and experimental development on biotechnology
DARK BLUE THERAPEUTICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Hayakawa Building, Edmund Halley Road The Oxford Science Park Oxford OX4 4GB United Kingdom
Full company profile for DARK BLUE THERAPEUTICS LTD (12645831), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 4 Jun 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2021–2025)
Cash in Bank
£822.16k
Net Assets
£4.95M
Total Liabilities
£935.82k
Turnover
N/A
Employees
14
Debt Ratio
16%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (4)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Jun 2020 | Unknown/Other |
| Investor 2 | Jun 2020 | Unknown/Other |
| Investor 3 | Jun 2020 | Unknown/Other |
See all 4 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| James Carmichael | Director | British | United Kingdom | 24 Jul 2020 | Active |
| Justian Craig Fox | Director | British | England | 16 May 2024 | Active |
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Amgen Uk Holdings Limited
Unknown
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Right To Appoint And Remove Directors
Bms Strategic Portfolio Investments Holdings, Inc.
United States Of America
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Oxford Science Enterprises Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Oxford Science Enterprises Plc
Ceased 17 Oct 2022
Evotec International Gmbh
Ceased 28 Jun 2024
Andrew James Mclean
Ceased 24 Jul 2020
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 10 Apr 2026 | Accounts | Annual accounts made up to 2026-06-30 | |
| 7 Mar 2026 | Resolution | Resolutions | |
| 4 Mar 2026 | Accounts | Annual accounts made up to 2025-06-30 | |
| 27 Feb 2026 | Capital | Allotment of shares (GBP 15,577.0144) on 2026-01-30 | |
| 23 Jan 2026 | Capital | Allotment of shares (GBP 15,281.1153) on 2025-12-30 |
Annual accounts made up to 2026-06-30
Resolutions
Annual accounts made up to 2025-06-30
Allotment of shares (GBP 15,577.0144) on 2026-01-30
Allotment of shares (GBP 15,281.1153) on 2025-12-30
Recent Activity
Latest Activity
Annual accounts made up to 2026-06-30
1 weeks ago on 10 Apr 2026
Resolutions
1 months ago on 7 Mar 2026
Annual accounts made up to 2025-06-30
1 months ago on 4 Mar 2026
Allotment of shares (GBP 15,577.0144) on 2026-01-30
1 months ago on 27 Feb 2026
Allotment of shares (GBP 15,281.1153) on 2025-12-30
2 months ago on 23 Jan 2026